1. Immunology and Inflammation

Ascorbic acid supports ex vivo generation of plasmacytoid dendritic cells from circulating hematopoietic stem cells

  1. Anders Laustsen
  2. Renée M van der Sluis
  3. Albert Gris-Oliver
  4. Sabina Sánchez Hernández
  5. Ena Cemalovic
  6. Hai Q Tang
  7. Lars Henning Pedersen
  8. Niels Uldbjerg
  9. Martin R Jakobsen  Is a corresponding author
  10. Rasmus O Bak  Is a corresponding author
  1. Aarhus University, Denmark
  2. Aarhus University Hospital, Denmark
  3. niels uldbjerg, Denmark
https://doi.org/10.7554/eLife.65528
Share this article
Cite this article
  1. Anders Laustsen
  2. Renée M van der Sluis
  3. Albert Gris-Oliver
  4. Sabina Sánchez Hernández
  5. Ena Cemalovic
  6. Hai Q Tang
  7. Lars Henning Pedersen
  8. Niels Uldbjerg
  9. Martin R Jakobsen
  10. Rasmus O Bak
(2021)
Ascorbic acid supports ex vivo generation of plasmacytoid dendritic cells from circulating hematopoietic stem cells
eLife 10:e65528.
https://doi.org/10.7554/eLife.65528
  2. Download BibTeX
  3. Download .RIS

Abstract

Plasmacytoid dendritic cells (pDCs) constitute a rare type of immune cell with multifaceted functions, but their potential use as a cell-based immunotherapy is challenged by the scarce cell numbers that can be extracted from blood. Here, we systematically investigate culture parameters for generating pDCs from hematopoietic stem and progenitor cells (HSPCs). Using optimized conditions combined with implementation of HSPC pre-expansion, we generate an average of 465 million HSPC-derived pDCs (HSPC-pDCs) starting from 100,000 cord blood-derived HSPCs. Furthermore, we demonstrate that such protocol allows HSPC-pDC generation from whole blood HSPCs, and these cells display a pDC phenotype and function. Using GMP compliant medium, we observe a remarkable loss of TLR7/9 responses, which is rescued by ascorbic acid supplementation. Ascorbic acid induces transcriptional signatures associated with pDC-specific innate immune pathways suggesting an undescribed role of ascorbic acid for pDC functionality. This constitutes the first protocol for generating pDCs from whole blood, and lay the foundation for investigating HSPC-pDCs for cell-based immunotherapy.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Sequencing data have been deposited in Dryad (doi:10.5061/dryad.69p8cz92z).

The following data sets were generated

Article and author information

Author details

  1. Anders Laustsen

    Department of Biomedicine, Aarhus University, Aarhus, Denmark
    Competing interests
    Anders Laustsen, Aarhus University has filed a patent related to this work with AL, MRJ, and ROB as co-inventors. AL, MRJ and ROB hold equity in the Danish company UNIKUM Therapeutics ApS. Part-time employees of UNIKUM Therapeutics ApS..

  2. Renée M van der Sluis

    Department of Biomedicine, Aarhus University, Aarhus C., Denmark
    Competing interests
    No competing interests declared.

  3. Albert Gris-Oliver

    Department of Biomedicine, Aarhus University, Aarhus, Denmark
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1802-9541

  4. Sabina Sánchez Hernández

    Department of Biomedicine, Aarhus University, Aarhus, Denmark
    Competing interests
    No competing interests declared.

  5. Ena Cemalovic

    Department of Biomedicine, Aarhus University, Aarhus, Denmark
    Competing interests
    No competing interests declared.

  6. Hai Q Tang

    Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus N., Denmark
    Competing interests
    No competing interests declared.

  7. Lars Henning Pedersen

    Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus N., Denmark
    Competing interests
    No competing interests declared.

  8. Niels Uldbjerg

    Department of Clinical Medicine, niels uldbjerg, Aarhus V, Denmark
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6449-6426

  9. Martin R Jakobsen

    Department of Biomedicine, Aarhus University, Aarhus, Denmark
    For correspondence
    mrj@biomed.au.dk
    Competing interests
    Martin R Jakobsen, Aarhus University has filed a patent related to this work with AL, MRJ, and ROB as co-inventors. AL, MRJ and ROB hold equity in the Danish company UNIKUM Therapeutics ApS. Serves on the board of directors of UNIKUM Therapeutics ApS..

  10. Rasmus O Bak

    Department of Biomedicine, Aarhus University, Aarhus C., Denmark
    For correspondence
    bak@biomed.au.dk
    Competing interests
    Rasmus O Bak, Aarhus University has filed a patent related to this work with AL, MRJ, and ROB as co-inventors. AL, MRJ and ROB hold equity in the Danish company UNIKUM Therapeutics ApS. Part-time employees of UNIKUM Therapeutics ApS. Holds equity in Graphite Bio..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7383-0297

Funding

Lundbeckfonden (R238-2016-3349)

  • Rasmus O Bak

Aarhus Institute of Advanced Studies, Aarhus Universitet

  • Renée M van der Sluis
  • Rasmus O Bak

European Union (609033)

  • Rasmus O Bak

Lundbeckfonden (R238-2016-2708)

  • Martin R Jakobsen

Independent Research Fund Denmark (8020-00201B)

  • Martin R Jakobsen

Novo Nordisk Fonden (NNF18OC0053146)

  • Martin R Jakobsen

European Union (754513)

  • Renée M van der Sluis

Carlsbergfondet (CF17-0129)

  • Rasmus O Bak

Carlsbergfondet (CF20-0424)

  • Rasmus O Bak

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: De-identified umbilical cord blood (UCB) samples were obtained following scheduled caesarean section deliveries of healthy infants at Department of Gynecology and Obstetrics, Skejby University Hospital. Consent was obtained from the mothers, but studies on anonymized samples, such as those used in the present study, are exempt from ethical permissions in Denmark (Kommiteeloven {section sign} {section sign}14. 3).Buffy coat samples were obtained from normal healthy donors from Aarhus University Hospital Blood Bank. These were de-identified samples and studies on anonymized samples are exempt from ethical permissions in Denmark (Kommiteeloven {section sign} {section sign}14. 3).

Copyright

© 2021, Laustsen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,877
    views
  • 267
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anders Laustsen
  2. Renée M van der Sluis
  3. Albert Gris-Oliver
  4. Sabina Sánchez Hernández
  5. Ena Cemalovic
  6. Hai Q Tang
  7. Lars Henning Pedersen
  8. Niels Uldbjerg
  9. Martin R Jakobsen
  10. Rasmus O Bak
(2021)
Ascorbic acid supports ex vivo generation of plasmacytoid dendritic cells from circulating hematopoietic stem cells
eLife 10:e65528.
https://doi.org/10.7554/eLife.65528

Share this article

https://doi.org/10.7554/eLife.65528

Categories and tags

Research organism

Further reading

    1. Immunology and Inflammation

    Inhibiting NINJ1-dependent plasma membrane rupture protects against inflammasome-induced blood coagulation and inflammation

    Jian Cui, Hua Li ... Congqing Wu
    Short Report

    Systemic blood coagulation accompanies inflammation during severe infections like sepsis and COVID. We previously established a link between coagulopathy and pyroptosis, a vital defense mechanism against infection. During pyroptosis, the formation of gasdermin-D (GSDMD) pores on the plasma membrane leads to the release of tissue factor (TF)-positive microvesicles (MVs) that are procoagulant. Mice lacking GSDMD release fewer of these procoagulant MVs. However, the specific mechanisms coupling the activation of GSDMD to MV release remain unclear. Plasma membrane rupture (PMR) in pyroptosis was recently reported to be actively mediated by the transmembrane protein Ninjurin-1 (NINJ1). Here, we show that NINJ1 promotes procoagulant MV release during pyroptosis. Haploinsufficiency or glycine inhibition of NINJ1 limited the release of procoagulant MVs and inflammatory cytokines, and partially protected against blood coagulation and lethality triggered by bacterial flagellin. Our findings suggest a crucial role for NINJ1-dependent PMR in inflammasome-induced blood coagulation and inflammation.

    1. Immunology and Inflammation

    Expression of a single inhibitory member of the Ly49 receptor family is sufficient to license NK cells for effector functions

    Sytse J Piersma, Shasha Li ... Wayne M Yokoyama
    Research Article

    Natural killer (NK) cells recognize target cells through germline-encoded activation and inhibitory receptors enabling effective immunity against viruses and cancer. The Ly49 receptor family in the mouse and killer immunoglobin-like receptor family in humans play a central role in NK cell immunity through recognition of major histocompatibility complex class I (MHC-I) and related molecules. Functionally, these receptor families are involved in the licensing and rejection of MHC-I-deficient cells through missing-self. The Ly49 family is highly polymorphic, making it challenging to detail the contributions of individual Ly49 receptors to NK cell function. Herein, we showed mice lacking expression of all Ly49s were unable to reject missing-self target cells in vivo, were defective in NK cell licensing, and displayed lower KLRG1 on the surface of NK cells. Expression of Ly49A alone on an H-2Dd background restored missing-self target cell rejection, NK cell licensing, and NK cell KLRG1 expression. Thus, a single inhibitory Ly49 receptor is sufficient to license NK cells and mediate missing-self in vivo.

    1. Immunology and Inflammation
    2. Neuroscience

    A microglia clonal inflammatory disorder in Alzheimer’s disease

    Rocio Vicario, Stamatina Fragkogianni ... Frédéric Geissmann
    Research Article

    Somatic genetic heterogeneity resulting from post-zygotic DNA mutations is widespread in human tissues and can cause diseases, however, few studies have investigated its role in neurodegenerative processes such as Alzheimer’s disease (AD). Here, we report the selective enrichment of microglia clones carrying pathogenic variants, that are not present in neuronal, glia/stromal cells, or blood, from patients with AD in comparison to age-matched controls. Notably, microglia-specific AD-associated variants preferentially target the MAPK pathway, including recurrent CBL ring-domain mutations. These variants activate ERK and drive a microglia transcriptional program characterized by a strong neuro-inflammatory response, both in vitro and in patients. Although the natural history of AD-associated microglial clones is difficult to establish in humans, microglial expression of a MAPK pathway activating variant was previously shown to cause neurodegeneration in mice, suggesting that AD-associated neuroinflammatory microglial clones may contribute to the neurodegenerative process in patients.